VANGUARD GROUP INC 13D and 13G filings for Vanda Pharmaceuticals Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-03-27 1:55 pm Sale | 2026-03-13 | 13G | VANDA PHARMACEUTICALS INC VNDA | VANGUARD GROUP INC | 0 0.000% | -3,456,087 (Position Closed) | Filing |
| 2024-02-13 5:16 pm Sale | 2023-12-29 | 13G | VANDA PHARMACEUTICALS INC VNDA | VANGUARD GROUP INC | 3,456,087 6.010% | -536,079 (-13.43%) | Filing |
| 2023-02-09 11:35 am Purchase | 2022-12-30 | 13G | VANDA PHARMACEUTICALS INC VNDA | VANGUARD GROUP INC | 3,992,166 7.050% | 115,482 (+2.98%) | Filing |
| 2022-02-10 08:42 am Sale | 2021-12-31 | 13G | VANDA PHARMACEUTICALS INC VNDA | VANGUARD GROUP INC | 3,876,684 6.960% | -82,396 (-2.08%) | Filing |